Updated report on trends in global PD-1/PD-L1 immunotherapy clinical development from the Cancer Research Institute published in Nature Reviews Drug Discovery.
Cancer Research Institute leverages data from GlobalData’s Pharma Intelligence platform in an immuno-oncology landscape update.
Latest immuno-oncology landscape report from the Cancer Research Institute published in Nature Reviews Drug Discovery highlights increasing global expansion and innovation.
The Cancer Research Institute and AER Technologies have partnered to raise vitals funds for the advancement of cancer immunotherapy research.
Cancer Research Institute announces 2019 recipients of its top scientific and philanthropic awards honoring discovery, service in advancing cancer immunology and immunotherapy research.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI’s focus on immunology research—while primarily aimed at curing cancer—also has contributed to advances in the treatment and prevention of infectious diseases.
We spoke with the five inaugural CRI Lloyd J. Old STARs to learn more about their work and what they hope to accomplish during the next five years.